NIFTYNXT50 Archives - ChartAlert®

CUMMINSIND – Cummins India – Q4 FY26 Earnings Call – 29-May-26

CUMMINSIND/ Cummins India’s topline growth hinges on data center and CPCB IV+ aftermarket; margins depend on commodity pass-through and HHP localization; Distribution remains resilient.

1–2 minutes

Also see: CUMMINSIND – Cummins India – Q4 FY26 Financial Results – 27-May-26

3-Scenario Framework

📊 Base Case (60% Probability)

Data center demand (30–35% of PowerGen) and CPCB IV+ aftermarket drive high single-digit revenue growth in FY27. Commodity pass-through lag and HHP import dependence cap margin expansion at ~50–100bps. Export growth remains flat (geopolitical caution). Distribution grows 15–20% (warranty exits, service packages).

DIVISLAB – Divi’s Laboratories – Q4 FY26 Earnings Call – 23-May-26

DIVISLAB/ Divi’s Laboratories’ topline growth remains robust (double-digit) on volume resilience and CS pipeline, but margins are structurally capped (~32%) by pricing pressure and cost inflation; bottomline stability hinges on forex and capex efficiency.

1–2 minutes

Also see: DIVISLAB – Divi’s Laboratories – Q4 FY26 Financial Results – 23-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Double-digit revenue growth sustained via volume stability in generics and gradual CS ramp-up. Margins remain flat at ~32% as RM/freight pressures offset INR benefits. Capex conversion cycle averages 2 years; FY27 capex at ~₹2,000 crores (18% of sales). Forex gains neutralize due to hedging.

CUMMINSIND – Cummins India – Q4 FY26 Financial Results – 27-May-26

Cummins India’s FY26 delivered 17% revenue and 18% PAT growth, debt‑free balance sheet, and ₹1,400 Cr FCF with ~160 bps margin expansion. Risks: ₹477 Cr receivables build and ₹503 Cr WC drag compressing FCF conversion. Strong industrial capex visibility, but sustaining premium valuations hinges on FCF quality.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 16.9% YoY (₹10,219 Cr → ₹11,950 Cr), driven entirely by the Engines segment — the sole reported business post-Lubes elimination.
Q4FY26 revenue at ₹2,963 Cr grew 22.1% YoY vs Q4FY25 (₹2,428 Cr), but dipped 1.4% QoQ from Q3’s ₹3,006 Cr — minor sequential softness.
Other income (₹517 Cr in FY26 vs ₹447 Cr in FY25) contributes meaningfully to reported profits; treasury income of ₹189 Cr is the primary driver.

Bottomline

Reported PAT grew 18.1% YoY (₹2,000 Cr → ₹2,362 Cr); adjusting for net exceptional charges of ₹82 Cr (FY26) vs nil (FY25), underlying PAT growth is closer to 22%.
Q4FY26 PAT at ₹649 Cr grew 22.7% YoY (vs ₹530 Cr in Q4FY25) and 33.6% QoQ — the Q3 base was depressed by ₹127 Cr labour code provision.
JV/associate profit contribution (Valvoline Cummins) held flat at ₹266 Cr YoY — no incremental earnings growth from this portfolio.

Margins

Operating margin (EBIT, pre-other income): Profit before exceptional items = ₹2,901 Cr on revenues of ₹11,950 Cr. Stripping other income (₹517 Cr) yields core EBIT of ~₹2,384 Cr on ₹11,950 Cr = ~20.0% core operating margin vs ~18.4% in FY25 (₹1,879 Cr / ₹10,219 Cr) — ~160 bps expansion YoY.
Net profit margin: ₹2,362 Cr / ₹11,950 Cr = 19.8% (FY26) vs ₹2,000 Cr / ₹10,219 Cr = 19.6% (FY25) — marginal expansion, as tax rate and exceptional items offset operating gains.
Employee costs declined slightly (₹797 Cr → ₹794 Cr) despite revenue growing 17% — meaningful operating leverage on the fixed-cost base.

Growth Trajectory

Three-year demand cycle in industrial/power generation engines remains intact; 17% topline growth on a ₹10,000 Cr+ base signals broad-based volume + mix improvement.
Lubes segment (Valvoline Cummins, 100% consolidated in segment but eliminated at group level) grew revenue 28% YoY (₹2,352 Cr → ₹3,009 Cr) — outpacing Engines; margin recovery notable.
Free cash flow (OCF ₹1,734 Cr less capex ₹252 Cr) = ₹1,482 Cr in FY26 vs ₹1,457 Cr in FY25 — FCF growth nearly flat despite 18% PAT growth, due to working capital absorption.

MOTHERSON – Samvardhana Motherson International – Q4 FY26 Earnings Call – 20-May-26

Samvardhana Motherson’s topline growth hinges on consumer electronics/aerospace scale-up, bottomline resilience depends on pass-through execution, and margins are structurally supported by diversification but cyclically pressured by commodity lags.

1–2 minutes

Also see: MOTHERSON – Samvardhana Motherson International – Q4 FY26 Financial Results – 20-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Consumer electronics doubles revenue (GF3 ramp in H2 FY27), aerospace grows 30% YoY, and automotive holds steady (EV at 15% of revenue by FY28). Margins stabilize at 9.5–10% as pass-throughs offset inflation. ROCE at 16–17%, leverage <1.0x, and dividend payout at 20%. USD 108B target remains aspirational but FY27 revenue at USD 26–28B.

BOSCHLTD – Bosch Limited – Q4 FY26 Earnings Call – 21-May-26

Bosch’s findings imply topline resilience (8–10% base-case growth) with margin expansion (50bps) hinging on cost controls and content per vehicle, while PAT growth (10–12%) is anchored by structural initiatives but vulnerable to macro shocks.

1–2 minutes

Also see: BOSCHLTD – Bosch Limited – Q4 FY26 Financial Results – 20-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Macro stability persists; crude oil rises 10%, but supply chain agility offsets costs. Flattish volume growth is offset by content per vehicle gains (CAFE Phase 3, ADAS). JV ramps up in FY’28, contributing 2–3% to revenue. Revenue grows 8–10%, EBITDA margins expand 50bps, and PAT grows 10–12%.

ZYDUSLIFE – Zydus Lifesciences – Q4 FY26 Earnings Call – 19-May-26

Zydus Lifesciences’ topline growth hinges on specialty scaling and international momentum, while margins and cash flow are sensitive to US generics competition, acquisition execution, and capex intensity.

1–2 minutes

Also see: ZYDUSLIFE – Zydus Lifesciences – Q4 FY26 Financial Results – 19-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Management delivers on high-teens revenue growth and >24% EBITDA margins in FY27. US generics decline offset by specialty/international growth, while MedTech/Comfort Click meet guidance. Capex/working capital pressure limits FCF growth, but leverage remains <1x net debt-to-EBITDA. Biosimilar scale-up aligns with FY29–30 timeline.

DIVISLAB – Divi’s Laboratories – Q4 FY26 Financial Results – 23-May-26

Divi’s FY26 delivered topline growth with rare margin expansion in APIs, funded capex doubling via accruals on debt‑free balance sheet. Risks: ₹718 Cr inventory build — demand vs procurement clarity due H1FY27. Strong OCF, accelerating exit rate, and expanding margins keep structural case intact despite FCF compression.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 12.8% YoY (₹9,360 Cr → ₹10,560 Cr), with Q4FY26 at ₹2,831 Cr — the strongest quarter of FY26, up 9.5% over Q4FY25’s ₹2,585 Cr.
Sequential revenue momentum held: Q2→Q3→Q4 progression of ₹2,604 Cr → ₹2,604 Cr → ₹2,831 Cr signals an accelerating exit rate into FY27.
Other income jumped 44% YoY (₹352 Cr → ₹507 Cr), driven by interest on FDs; operationally irrelevant but flatters total income.

Bottomline

Net profit grew 17.2% YoY (₹2,191 Cr → ₹2,568 Cr), outpacing revenue — positive operating leverage at work.
Q4FY26 PAT of ₹751 Cr was the highest quarterly print, up 13.4% over Q4FY25’s ₹662 Cr; sequential jump from ₹583 Cr reflects Q3’s one-time labour code charge of ₹74 Cr normalising out.
Basic EPS expanded from ₹82.53 to ₹96.75 — a 17.2% YoY improvement on an unchanged share count.

Margins

EBITDA (PBT ex-other income + depreciation + finance costs): FY26 = ₹3,462 – ₹507 + ₹463 + ₹23 = ₹3,441 Cr on revenue of ₹10,560 Cr → EBITDA margin 32.6% vs FY25: ₹2,916 – ₹352 + ₹402 + ₹2 = ₹2,968 Cr on ₹9,360 Cr → 31.7%. ~90 bps expansion YoY.
Net profit margin (PAT/Revenue from ops): FY26 = 2,568/10,560 = 24.3% vs FY25 = 2,191/9,360 = 23.4%. ~90 bps improvement.
Employee costs grew 16% YoY (₹1,243 Cr → ₹1,442 Cr) and material costs grew 14.6% (₹3,821 Cr → ₹4,378 Cr net of inventory change: ₹3,821–96 = ₹3,725 Cr FY25 vs ₹4,378–285 = ₹4,093 Cr FY26, +9.9%) — cost discipline preserved margin expansion.

Growth Trajectory

Revenue CAGR trajectory: 12.8% in FY26; combined with margin expansion, the earnings growth of 17.2% YoY demonstrates operating leverage materialising at scale.
CWIP nearly doubled (₹1,022 Cr → ₹2,113 Cr) and capex was ₹2,520 Cr in FY26 vs ₹1,438 Cr in FY25 — a 75% capex step-up signals management’s confidence in sustaining double-digit volume growth.
Total equity grew from ₹14,969 Cr to ₹16,761 Cr, entirely through retained earnings; the asset base expanded from ₹16,932 Cr to ₹20,033 Cr — 18.3% in one year.

CGPOWER – CG Power – Q4 FY26 Earnings Call – 6-May-26

CG Power’s topline growth hinges on Power Systems execution and export scaling; margins depend on commodity pass-through and semiconductor ramp-up; ROCE sustainability tied to capex efficiency and working capital management.

1–2 minutes

Also see: CGPOWER – CG Power – Q4 FY26 Financial Results – 6-May-26

3-Scenario Framework

📊 Base Case (60% Probability)

Power Systems sustains 15–20% revenue growth (domestic + exports) with 250–300bps margin expansion via operating leverage. Transformer capacity hits 110K MVA by end-2026, supporting INR15,000+ cr order backlog execution. Semiconductor G2 facility on track (end-2026), contributing INR500–1,000 cr revenue in FY27. ROCE stabilizes at 22–24%, PAT grows 20–25% YoY.

DMART – Avenue Supermarts – Q4 FY26 Investor Presentation – 2-May-26

DMART/ Avenue Supermarts’ topline resilience hinges on Foods demand, while margins and bottomline face pressure from FMCG mix erosion and operational leverage limits.

1–2 minutes

Also see: DMART – Avenue Supermarts – Q4 FY26 Financial Results – 2-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

LFL growth ~5-7%, with Foods revenue share stable at ~58%. FMCG mix declines marginally to ~19%, pressuring gross margins. Inventory turnover flat, keeping working capital neutral. ROCE stable but debt leverage limits upside.

MAZDOCK – Mazagon Dock Shipbuilders – Q4 FY26 Investor Presentation – 30-Apr-26

MAZDOCK/ Mazagon Dock Shipbuilders’ topline growth hinges on execution and MoD dependencies, while margins and cash flows are sensitive to indigenization and working capital management.

1–2 minutes

Also see: MAZDOCK – Mazagon Dock Shipbuilders – Q4 FY26 Financial Results – 30-Apr-26

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Moderate delays in P17A, partial success in indigenization, stable MoD budgets.
Outcome: Revenue CAGR 10-12%, EBITDA margins 25-27%, and dividend yield ~3.5%. Order book remains ₹20,000-22,000 Cr with gradual diversification.